Volume 15, Issue 4 pp. 354-366
Research Article
Full Access

β-galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement

A. Morrone

A. Morrone

Department of Paediatrics, University of Florence, Florence, Italy

A. Morrone and T. Bardelli contributed equally to this work.

Search for more papers by this author
T. Bardelli

T. Bardelli

Department of Paediatrics, University of Florence, Florence, Italy

A. Morrone and T. Bardelli contributed equally to this work.

Search for more papers by this author
M.A. Donati

M.A. Donati

Department of Paediatrics, University of Florence, Florence, Italy

Search for more papers by this author
M. Giorgi

M. Giorgi

Department of Paediatrics, University of Florence, Florence, Italy

Search for more papers by this author
M. Di Rocco

M. Di Rocco

Gaslini Institute, Genoa, Italy

Search for more papers by this author
R. Gatti

R. Gatti

Gaslini Institute, Genoa, Italy

Search for more papers by this author
R. Parini

R. Parini

Clinical Paediatrics II°, Milan, Italy

Search for more papers by this author
R. Ricci

R. Ricci

Catholic University, Rome, Italy

Search for more papers by this author
G. Taddeucci

G. Taddeucci

Department of Paediatrics, University of Pisa, Pisa, Italy

Search for more papers by this author
A. D'Azzo

A. D'Azzo

Department of Genetics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA

Search for more papers by this author
E. Zammarchi

Corresponding Author

E. Zammarchi

Department of Paediatrics, University of Florence, Florence, Italy

Dipartimento di Pediatria, Università di Firenze, Azienda Ospedaliera “A. Meyer”, Via Luca Giordano 13, 50132 Firenze, ItalySearch for more papers by this author

Abstract

GM1-gangliosidosis is a lysosomal storage disorder caused by deficiency of acid β-galactosidase (GLB1). We report five new β-galactosidase gene mutations in nine Italian patients and one fetus, segregating in seven unrelated families. Six of the eight patients with the infantile, severe form of the disease presented cardiac involvement, a feature rarely associated with GM1-gangliosidosis. Molecular analysis of the patients' RNA and DNA identified two new RNA splicing defects, three new and three previously described amino acid substitutions. Interestingly, all patients with cardiac involvement were homozygous for one of these mutations: R59H, Y591C, Y591N, or IVS14-2A>G. In contrast, all other patients were compound heterozygous for one of the following mutations: R201H, R482H, G579D, IVS8+2T>C. Although we could not directly correlate the presence of cardiac abnormalities with specific genetic lesions, the mutations identified in patients with cardiomyopathy fell in the GLB1 cDNA region common to the lysosomal enzyme and the Hβ-Gal-related protein, also known as the elastin binding protein (EBP). Consequently, both molecules are affected by the mutations, and they may contribute differently to the occurrence of specific clinical manifestations. Hum Mutat 15:354–366, 2000. © 2000 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.